Insiders · Profile

Farzan Nima

Director at Keros Therapeutics. Filing since 4 Jun 2026. CIK 0001808296

Company

Date

Role

Action

Shares

Amount

Of holding

KROS Keros Therapeutics, Inc.

4 Jun 2026

Director

Sold on a plan

2,625

$28.17K

21.2%

1 decision on file.